Edgewood Management - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Edgewood Management ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$742,500
-12.6%
30,0000.0%0.00%
-33.3%
Q2 2023$849,600
+23.3%
30,0000.0%0.00%
+50.0%
Q1 2023$689,100
-18.2%
30,0000.0%0.00%
-33.3%
Q4 2022$842,400
-0.7%
30,0000.0%0.00%0.0%
Q3 2022$848,000
+45.7%
30,000
+50.0%
0.00%
+200.0%
Q1 2022$582,00020,0000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders